NeuroMetrix, Inc. (NURO) Reports Second Quarter 2014 Financial Results and Business Highlights
7/24/2014 11:19:29 AM
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), today reported business highlights for the quarter ended June 30, 2014.
The Company operates in two primary markets - wearable medical technology and point-of-care tests. The Company's SENSUS device is a wearable transcutaneous electrical nerve stimulator indicated for management of chronic pain, and is the only such device cleared by the FDA for use during sleep.
Help employers find you! Check out all the jobs and post your resume.
comments powered by